Margot Jak

653 total citations
23 papers, 394 citations indexed

About

Margot Jak is a scholar working on Genetics, Oncology and Hematology. According to data from OpenAlex, Margot Jak has authored 23 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 11 papers in Oncology and 7 papers in Hematology. Recurrent topics in Margot Jak's work include Chronic Lymphocytic Leukemia Research (11 papers), CAR-T cell therapy research (5 papers) and Multiple Myeloma Research and Treatments (5 papers). Margot Jak is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), CAR-T cell therapy research (5 papers) and Multiple Myeloma Research and Treatments (5 papers). Margot Jak collaborates with scholars based in Netherlands, Switzerland and United States. Margot Jak's co-authors include Marinus H. J. van Oers, Eric Eldering, René A. W. van Lier, Ester B. M. Remmerswaal, Rogier Mous, René Spijker, Jacqueline M. Tromp, Annelieke Jaspers, Arnon P. Kater and María Fernanda Pascutti and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Margot Jak

20 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margot Jak Netherlands 8 209 199 149 116 89 23 394
Dieuwertje M. Luijks Netherlands 8 241 1.2× 145 0.7× 92 0.6× 118 1.0× 135 1.5× 11 353
Shih‐Shih Chen United States 12 321 1.5× 236 1.2× 118 0.8× 214 1.8× 126 1.4× 41 494
Philipp M. Roessner Germany 11 269 1.3× 221 1.1× 171 1.1× 137 1.2× 97 1.1× 20 406
Valentina Griggio Italy 10 193 0.9× 208 1.0× 144 1.0× 90 0.8× 75 0.8× 18 362
Sandeep Potluri United Kingdom 8 144 0.7× 98 0.5× 95 0.6× 134 1.2× 93 1.0× 12 312
Noelia Purroy Spain 10 159 0.8× 123 0.6× 88 0.6× 136 1.2× 113 1.3× 18 334
Davide Bagnara United States 12 253 1.2× 345 1.7× 106 0.7× 164 1.4× 106 1.2× 29 511
Raimundo Bezares Argentina 14 212 1.0× 185 0.9× 81 0.5× 115 1.0× 116 1.3× 29 400
Gianluca Schiavoni Italy 10 276 1.3× 128 0.6× 114 0.8× 177 1.5× 184 2.1× 17 440
Dania Benedetti Italy 9 265 1.3× 189 0.9× 60 0.4× 161 1.4× 104 1.2× 17 381

Countries citing papers authored by Margot Jak

Since Specialization
Citations

This map shows the geographic impact of Margot Jak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margot Jak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margot Jak more than expected).

Fields of papers citing papers by Margot Jak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margot Jak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margot Jak. The network helps show where Margot Jak may publish in the future.

Co-authorship network of co-authors of Margot Jak

This figure shows the co-authorship network connecting the top 25 collaborators of Margot Jak. A scholar is included among the top collaborators of Margot Jak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margot Jak. Margot Jak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vos, Laura M., et al.. (2025). Disseminated histoplasmosis induced hemophagocytic lymphohistiocytosis in an immunocompromised patient. Clinical Infection in Practice. 26. 100488–100488.
2.
3.
Cuenca, Marta, et al.. (2023). Identifying clinical response to daratumumab therapy in relapsed/refractory multiple myeloma using a patient‐derived in vitro model. SHILAP Revista de lepidopterología. 5(1). 141–146. 1 indexed citations
4.
Doesum, Jaap A. van, Anne M. Spanjaart, Margot Jak, et al.. (2023). Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities. Cancers. 15(22). 5443–5443. 9 indexed citations
5.
Gant, Christina M., Tri Q. Nguyen, Alferso C Abrahams, et al.. (2023). Cryoglobulinemic Vasculitis in Disguise: Cryofibrinogenemia as Variant of Monoclonal Gammopathy of Renal Significance. American Journal of Kidney Diseases. 83(3). 415–419. 3 indexed citations
6.
Kleinjan, Ankie, Jaap A. van Doesum, Anne M. Spanjaart, et al.. (2023). Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy. Blood Advances. 7(21). 6710–6716. 6 indexed citations
7.
Spanjaart, Anne M., Milan Kos, Pim Mutsaers, et al.. (2022). Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO Oncology Practice. 19(3). e407–e416. 7 indexed citations
8.
Jak, Margot, Bas H. M. van der Velden, Bart de Keizer, et al.. (2022). Prediction of Poor Outcome after Tisagenlecleucel in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL) Using Artificial Intelligence Analysis of Pre-Infusion PET/CT. Blood. 140(Supplement 1). 1919–1920. 2 indexed citations
9.
Cuenca, Marta, et al.. (2021). In Vitro Model to Predict Response to Daratumumab Therapy in Relapsed/Refractory Multiple Myeloma. Blood. 138(Supplement 1). 1568–1568. 1 indexed citations
10.
Minnema, Monique C., Rimke Oostvogels, Reinier Raymakers, & Margot Jak. (2021). Differences and Similarities in Treatment Paradigms and Goals between AL Amyloidosis and Multiple Myeloma. SHILAP Revista de lepidopterología. 2(4). 680–691. 1 indexed citations
11.
Cuenca, Marta, et al.. (2019). CD38 and CD45 expression on plasma cells and response to daratumumab in Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 19(10). e164–e164.
12.
Evers, Mitchell, Margot Jak, & Jeanette H.W. Leusen. (2018). The latest developments with anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia. Expert Opinion on Biological Therapy. 18(9). 973–982. 7 indexed citations
13.
Oostvogels, Rimke, Margot Jak, Reinier Raymakers, Rogier Mous, & Monique C. Minnema. (2018). Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients. British Journal of Haematology. 183(1). 60–67. 21 indexed citations
14.
Pascutti, María Fernanda, Margot Jak, Jacqueline M. Tromp, et al.. (2013). IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells. Blood. 122(17). 3010–3019. 107 indexed citations
15.
Jak, Margot, et al.. (2011). CD40 stimulation sensitizes CLL cells to rituximab-induced cell death. Leukemia. 25(6). 968–978. 28 indexed citations
16.
Jak, Margot, Eric A. Reits, Wouter W. Kallemeijn, et al.. (2011). CD40 stimulation sensitizes CLL cells to lysosomal cell death induction by type II anti-CD20 mAb GA101. Blood. 118(19). 5178–5188. 36 indexed citations
17.
Jak, Margot, et al.. (2010). CD40 Stimulation Sensitizes CLL Cells to CD20-Triggered Cell Death by Rituximab and GA101 Via a Different Mechanism. Blood. 116(21). 3979–3979. 1 indexed citations
18.
Jak, Margot, Rogier Mous, Ester B. M. Remmerswaal, et al.. (2009). Enhanced formation and survival of CD4+CD25hiFoxp3+T-cells in chronic lymphocytic leukemia. Leukemia & lymphoma. 50(5). 788–801. 91 indexed citations
19.
Spijker, René, Margot Jak, Nuno L. Alves, et al.. (2007). Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protection. Cell Death and Differentiation. 14(11). 1958–1967. 45 indexed citations
20.
Arens, Ramon, Paul A. Baars, Margot Jak, et al.. (2005). Cutting Edge: CD95 Maintains Effector T Cell Homeostasis in Chronic Immune Activation. The Journal of Immunology. 174(10). 5915–5920. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dieuwertje M. Luijks Breakdown of academic impact, for papers by Shih‐Shih Chen Breakdown of academic impact, for papers by Philipp M. Roessner Breakdown of academic impact, for papers by Valentina Griggio Breakdown of academic impact, for papers by Sandeep Potluri Breakdown of academic impact, for papers by Noelia Purroy Breakdown of academic impact, for papers by Davide Bagnara Breakdown of academic impact, for papers by Raimundo Bezares Breakdown of academic impact, for papers by Gianluca Schiavoni Breakdown of academic impact, for papers by Dania Benedetti
Rankless by CCL
2026